This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer's Disease and Parkinson's Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies.
CNS drugs, 39(12), 1201-1220
Citation
Hölscher, Christian. (2025). Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer's Disease and Parkinson's Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies.. CNS drugs, 39(12), 1201-1220. https://doi.org/10.1007/s40263-025-01226-z